Anti Park in Son MODELS
Anti Park in Son MODELS
Anti Park in Son MODELS
In Vitro Models.
In Vivo Models.
References.
Parkinsons disease is a degenerative disorder of CNS comprising four cardinal feature: Tremor Rigidity, Akinesia, Postural instability (TRAP)
NORMAL
PARKINSONS DISEASE
4
Definite: Old age. Probable: Positive family history. Possible: Herbicides, pesticides, heavy metals, proximity to industry, rural residence, well water, repeated head trauma, etc.
Models are required for screening the Anti PD Drug. Models are the replica of the disease state in human i.e. models are the replica of the diseased human. Models can help observe the biochemical changes causing the disease or caused by the disease.
Reserpine antagonism.
Elevated body swing test.
10
They are dosed orally with the standard (5mg/kg Benzatropine mesilate) & test compound 1 hr. prior to administration of 0.5mg/kg Oxotremorine s.c.
Rectal temp. is measured before administration of the compound(Basal value) & 1, 2 & 3 hr. after oxotremorine injection.
Tremor is scored after oxotremorine dosage in 10-s observation periods every 15min for 1 h.
Salivation and lacrimation are scored 15 and 30min after oxotremorine injection.
11
0 1 2 3
12
Hypothermia: The differences of body temperature after 1, 2 and 3 hr versus basal values are summarized for each animal in the control group and the test groups. The average values are compared statistically. Tremor: The scores for all animals in each group at the three observation periods are summarized. The numbers in the treated groups are expressed as percentage of the number of the control group.
13
14
PURPOSE AND RATIONALE MPTP (N-methyl-4-phenyl-1,2,3,6tetrahydropyridine) has been shown to cause symptoms of Parkinsons disease in exposed individuals.
15
8 adult rhesus monkeys weighing 5-8kg were treated with MPTP (1018mg/kg, i.v.) over a period of 5-8 days.
The animals showed a Parkinsons like disorder which was reveresed by L-Dopa administration.
The pathological & biochemical changes produced by MPTP were similar to the patient with PD.
16
The severity of parkinson symptoms is rated by trained observers using a scale of 0 (normal) to 17 (maximum severity) that assesses: Movement (0: normal;1: reduced; 2: sleepy), Checking movements (0: present; 1: reduced; 2: absent), Attention and blinking (0: normal; 1: abnormal), Posture (0: normal; 1: abnormal trunk; 2: abnormal trunk and tail; 3: abnormal trunk, tail, and limbs; 4: flexed posture), Balance and coordination (0: normal; 1: impaired; 2: unstable; 4: falls), Reactions (0: normal; 1: reduced; 2: slow; 3: absent) Vocalizations (0: normal; 1: reduced; 2: absent).
17
18
Male NMRI mice weighing 20-25 gm are injected by Reserpine (5mg/kg, i.p.) before 24 hr of expt.
The animals are placed singly onto the floor of a Perspex container(30 26 cm, 20 cm high), situated on a Panlab proximity sensor unit.
19
Locomotor activity and grooming scores of drug treated animals are compared with controls treated with reserpine and vehicle only by analysis of variance.
20
1.
Goodman & Gilmons, The Pharmacological Basis Of Therapeutics. By Laurence L. Brunton, John S. Lazo. Keith L.
H. Gerhard Vogel(Ed.), 2008; Second Edition, Drug Discovery and Evaluation Pharmacological Assays, Springer Publication Page : 820-822, 824-829. K. D. Tripathi,2009; Sixth Edition, Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers, Page : 416.
21
22